Letters to the Editor

A patient with minimal myeloma treatment who survived for 20 years

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Hematology, St. Olavs Hospital, Trondheim
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Hematology, St. Olavs Hospital, Trondheim
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Hematology, St. Olavs Hospital, Trondheim
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Medical Genetics, St. Olavs Hospital, Trondheim
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Biobank1, St. Olavs Hospital, Trondheim
Haematologica Early view Oct 5, 2023 https://doi.org/10.3324/haematol.2023.283563